Meet our Clinical Advisory Board
In conjunction with launching clinical trials in 2014, we formed our Clinical Advisory Board. Its members are globally recognized medical specialists with substantial experience and expertise in clinical trial protocol design.
Dean and Professor of Medicine Chinese University of Hong Kong, China
MD Chinese University of Hong Kong
Dr. Chan has received numerous awards, including The David Y. Graham Lecturer Award and the Leadership Award from the American College of Gastroenterology. He has published extensively in leading medical journals, including The New England Journal of Medicine and The Lancet.
“The need for a new generation of pain and inflammation drugs has never been more urgent.”
Professor of Medicine and Chief of Gastroenterology University Hospital, Institute of Health Sciences, Zaragoza, Spain
MD University of Zaragoza, Spain
Dr Lanas has published more than 350 articles in leading medical journals, including The New England Journal of Medicine, Nature, and The Lancet.
“We now know that NSAIDs can also damage the small intestine, a fact only confirmed with the recent availability of capsule endoscopy.”
Chief, Division of Gastroenterology & Hepatology University of Virginia Health System, USA
MD University of Michigan, USA
Dr. Scheiman’s research on preventing gastrointestinal damage by NSAIDs has defined today’s clinical approach to this drug class. He is the author of more than 250 original scientific publications and book chapters.
“NSAIDs are effective medicines—we need to develop strategies to reduce gastrointestinal and other adverse events associated with their use.”
Division Chief, Rheumatology and Director, Arthritis Program Southlake Regional Health Centre, Ontario, Canada
MD Faculty of Medicine, University of Toronto, Canada
Dr. Thorne is the recipient of Distinguished Rheumatologist Award from the American College of Rheumatology.
“As a physician and scientist, I am constantly aware of the difficult tradeoffs inherent in today’s pain medications.”